The global Cancer Biomarkers Market is expected to grow at a CAGR of 12% during the forecast period, from USD 11.98 billion in 2022 to USD 33.22 billion in 2032. This growth can be attributed to the increasing prevalence of cancer worldwide, the high demand for personalized medicine, and the rising use of diagnostic tests based on biomarkers.   Biomarkers are biological molecules or...